Table I.

Patient background.

Characteristic	Total (n=44)	HLA-A*2402 (n=28)	non-HLA-A*2402 (n=16)	P-value
Age, median (range), years	64 (37–80)	63 (37–76)	64 (47–80)	n.s.
Sex, n (%)
Male	20 (45%)	14 (50%)	6 (37%)	n.s.
Female	24 (55%)	14 (50%)	10 (63%)
Number of vaccination, median (range)	30 (21–30)	30 (21–30)	30 (30–30)	n.s.
Colon/rectum, n (%)
Colon	25 (57%)	17 (61%)	7 (43%)	n.s.
Rectum	19 (43%)	11 (39%)	9 (57%)
Location of primary tumor, n (%)
Right	9 (20%)	7 (25%)	5 (31%)	n.s.
Left	26 (60%)	21 (75%)	10 (69%)
Stage, n (%)
IIIa	28 (64%)	15 (54%)	13 (81%)	n.s.
IIIb	16 (36%)	13 (46%)	3 (19%)

HLA-A, human leukocyte antigen-A; n.s., not significant.